drugset / Trial / NCT00751556
Single/Multiple Dose Bioavailability Trial
RandomizedCrossoverOpen-labelTreatment
Summary
To determine the pharmacokinetic profile of an extended release tablet of naproxen sodium 660 mg relative to the established commercial Aleve 220 mg tablet following single dose administration and at steady-state following multiple dose administration for 4 days.
Timeline
- Start
- 2008-02
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naproxen | Small molecule | 220 mg | — |
| Subject | Naproxen | Small molecule | 660 mg | — |
Indications
No indication recorded.